Venture
Affiliations
New York University
Technologies
Diagnostic
Digital Health Technology
Indication
Central Nervous System Disorders
Clinical Research
Drug Discovery
Musculoskeletal Disorders
Oncology
We are a service company that improves medical image quality via advanced post-processing and uses this improvement to develop quantitive biomarkers specific to cellular-level pathology.
Team:
Lieven Nuyttens, CEO
Gregory Lemberskiy, CTO